CLDN3 and psoriasis: Serum expression levels of Claudin-3 and I-FABP can serve as quantitative indicators of intestinal barrier integrity, with elevated levels predicting the risk of psoriasis recurrence (Sikora et al., 2019; Lai et al., 2023).